drugset / Trial / NCT03719053
Single Dose Truvada Study
NaSingle-groupOpen-labelOther
Summary
This study examines tenofovir (TFV) drug concentrations in adults one day after taking a single dose of Truvada® - a pill used to prevent and treat HIV infection. The results of this study will be used to improve the (efficacy/accuracy) of a white coat adherence (WCA) detection test - a blood test that can be used to indicate medication adherence. Participants will receive one dose of Truvada®, and provide 2 total samples of blood.
Timeline
- Start
- 2018-10-25
- Primary completion
- 2020-06-30
- Completion
- 2020-06-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Tenofovir | Small molecule | 300 mg | Oral |
| Background | emtricitabine | Other / unclassified | — | Oral |
Indications
No indication recorded.